Women's health pertains to the area of medicine and healthcare dedicated to diagnosing, treating, and preventing diseases and conditions that uniquely impact women. This field covers various issues, including reproductive health, menstrual health, pregnancy and childbirth, menopause, and conditions like breast and ovarian cancers. It also tackles other health concerns that disproportionately affect women, such as osteoporosis, cardiovascular disease, and autoimmune disorders.
The primary categories of products related to women's health include devices, drugs, and pharmaceutical pipelines. Women's health devices are instrumental in treating medical conditions specific to women. This includes individuals aged 50 years and older, who may undergo hormonal treatment, non-hormonal treatment, and surgeries for a range of applications. These applications span postmenopausal osteoporosis, hormonal infertility, endometriosis, uterine fibroids, contraceptives, menopause, and polycystic ovary syndrome (PCOS). These women's health products are made available through various distribution channels, including hospitals, retail stores, and online pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The women's health market research report is one of a series of new reports from The Business Research Company that provides women's health market statistics, including women's health industry global market size, regional shares, competitors with a women's health market share, detailed women's health market segments, market trends and opportunities, and any further data you may need to thrive in the women's health industry. This women's health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The women's health market size has grown steadily in recent years. It will grow from $43.53 billion in 2024 to $45.36 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to advancements in reproductive medicine, awareness and education initiatives, empowerment and advocacy movements, prenatal and postnatal care advances, development of hormone replacement therapies.
The women's health market size is expected to see strong growth in the next few years. It will grow to $57.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to precision medicine in gynecology, rise in female-focused clinical trials, expanded use of non-invasive prenatal testing, expanded access to fertility treatments, increasing focus on mental health. Major trends in the forecast period include digital health solutions, fertility tracking and reproductive health, non-hormonal contraceptive options, maternal health and pregnancy monitoring, innovations in women's health diagnostics, integration of artificial intelligence (AI).
The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. providers by driving up the cost of mammography systems and hormonal therapies sourced from Germany and India, exacerbating screening delays and increasing gynecological care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The escalating prevalence of women-centric diseases stands as a significant driver propelling the growth trajectory of the women's health market. A surge in conditions such as anemia, osteoporosis, breast cancer, menopause, and others, attributed to diverse risk factors like family history, advancing age, early onset of menstruation or menopause post-55 years, obesity, among others, is fueling the demand for women's health products and services. These offerings cater to treating these diseases while prioritizing the overall health and wellness of women. For example, the American Cancer Society's report published in January 2023 highlighted cervical cancer's historical status as a leading cause of cancer-related deaths among American women. An estimated 13,960 new cases of invasive cervical cancer are projected to be diagnosed in the USA in 2023, with approximately 4,310 anticipated fatalities. Hence, the escalating incidence of women-centric diseases is steering the expansion of the women's health market.
An upsurge in the aging populace emerges as a significant catalyst propelling the advancement of the women's health market. The demographic shift towards an aging population, characterized by a burgeoning proportion of individuals aged 65 and above, necessitates an increased focus on women's health needs. Women within this demographic encounter a higher prevalence of diseases such as osteoporosis, breast cancer, and menopause-related issues. This demographic shift underscores the augmented demand for specialized women's health services and products. It accentuates the significance of preventive measures, screenings, and tailored healthcare interventions aimed at preserving the well-being and enhancing the quality of life for older women. Notably, the World Health Organization's October 2022 report predicts that by 2030, 1 in 6 individuals globally will be aged 60 years or older, with the population of people aged 60 years and older anticipated to double by 2050, reaching 2.1 billion. Thus, the burgeoning aging population significantly propels the women's health market.
Developments in women's health represent a significant trend within the women's health market. Leading companies in this sector are creating new products to bolster their market position. For example, in July 2022, GE Healthcare, a US-based medical technology firm, introduced the Voluson Expert 22. This new addition to the company's women's health portfolio utilizes graphic-based beam former technology, providing exceptional image quality and improved flexibility in imaging capabilities. The system is equipped with advanced tools powered by Artificial Intelligence (AI), ensuring greater consistency in examinations while minimizing the number of tasks needed.
Major players in the women's health market are integrating innovative technologies like Transcutaneous Electrical Nerve Stimulation (TENS) to solidify their position. TENS is a non-invasive therapeutic technique involving a battery-operated device that emits low-voltage electrical currents through electrode pads placed on specific body areas. This technology, exemplified by Myoovi's September 2023 launch in the UK, offers relief for painful menstruation cramps. By generating electrical signals, TENS interferes with and obstructs pain signals attempting to reach the brain, thereby minimizing pain. This drug-free alternative helps women manage the discomfort associated with menstrual cramps, offering a promising solution.
In March 2024, Halma, a UK-based technology firm, acquired Rovers Medical Devices (Rovers) for $92.63 million. This acquisition expands Halma's offerings in the women's health sector, specifically in cervical cancer diagnostics, and supports its objective of enhancing its position in cancer diagnosis products. Rovers Medical Devices, based in the Netherlands, specializes in designing and manufacturing sample collection devices intended for the diagnosis and prevention of cervical cancer.
Major companies operating in the women's health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Scailyte AG, Syrona Health AG
North America was the largest region in the women's health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women's health market report during the forecast period. The regions covered in the women's health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the women's health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The women's health market consists of revenues earned by entities by providing hormone therapy, birth control treatment, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The women's health market also includes sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics or gynecology biopsy, imaging devices, and drugs such as Xgeva, Evista, Mirena, Zometa, Reclast, and Class, among others, that are used in providing women's health services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Women's Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on women's health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for women's health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The women's health market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline
- 2) By Age: 50 Years & above ; Other Ages
- 3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries
- 4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)
- 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Devices: Diagnostic Devices; Contraceptive Devices; Fertility Monitoring Devices; Gynecological Surgical Devices; Breast Pumps
- 2) By Drugs: Hormonal Therapies; Fertility Drugs; Osteoporosis Drugs; Menopause Treatment Drugs; Endometriosis Drugs; Contraceptives
- 3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause; New Fertility Treatments; Novel Contraceptives; Drugs for Gynecological Conditions; Hormone Replacement Therapy Developments
- Companies Mentioned: AbbVie Inc.; Bayer AG; Merck & Co Inc.; Pfizer Inc.; Agile Therapeutics; Apothecus Pharmaceutical Corporation; Blairex Laboratories Inc.; Novartis AG; AstraZeneca PLC; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuticals; Lupin Pharmaceuticals Inc.; Johnson & Johnson Services Inc.; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Hologic Inc.; Celmatix Inc.; HERA Biotech Inc.; Juno Bio Inc.; Maven Clinic Inc.; MobileODT Ltd.; Mylan N.V.; ObsEva SA; Scailyte AG; Syrona Health AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Women's Health Market Characteristics
3. Women's Health Market Trends And Strategies
4. Women's Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Women's Health Growth Analysis And Strategic Analysis Framework
- 5.1. Global Women's Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Women's Health Market Growth Rate Analysis
- 5.4. Global Women's Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Women's Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Women's Health Total Addressable Market (TAM)
6. Women's Health Market Segmentation
- 6.1. Global Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Devices
- Drugs
- Pharmaceutical Pipeline
- 6.2. Global Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 50 Years & above
- Other Ages
- 6.3. Global Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormonal Treatment
- Non-Hormonal Treatment
- Surgeries
- 6.4. Global Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Women's Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Endometriosis & Uterine Fibroids
- Contraceptives
- Menopause
- Polycystic Ovary Syndrome (PCOS)
- 6.6. Global Women's Health Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Devices
- Contraceptive Devices
- Fertility Monitoring Devices
- Gynecological Surgical Devices
- Breast Pumps
- 6.7. Global Women's Health Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormonal Therapies
- Fertility Drugs
- Osteoporosis Drugs
- Menopause Treatment Drugs
- Endometriosis Drugs
- Contraceptives
- 6.8. Global Women's Health Market, Sub-Segmentation Of Pharmaceutical Pipeline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Emerging Drugs for Menopause
- New Fertility Treatments
- Novel Contraceptives
- Drugs for Gynecological Conditions
- Hormone Replacement Therapy Developments
7. Women's Health Market Regional And Country Analysis
- 7.1. Global Women's Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Women's Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Women's Health Market
- 8.1. Asia-Pacific Women's Health Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Women's Health Market
- 9.1. China Women's Health Market Overview
- 9.2. China Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Women's Health Market
- 10.1. India Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Women's Health Market
- 11.1. Japan Women's Health Market Overview
- 11.2. Japan Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Women's Health Market
- 12.1. Australia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Women's Health Market
- 13.1. Indonesia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Women's Health Market
- 14.1. South Korea Women's Health Market Overview
- 14.2. South Korea Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Women's Health Market
- 15.1. Western Europe Women's Health Market Overview
- 15.2. Western Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Women's Health Market
- 16.1. UK Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Women's Health Market
- 17.1. Germany Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Women's Health Market
- 18.1. France Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Women's Health Market
- 19.1. Italy Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Women's Health Market
- 20.1. Spain Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Women's Health Market
- 21.1. Eastern Europe Women's Health Market Overview
- 21.2. Eastern Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Women's Health Market
- 22.1. Russia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Women's Health Market
- 23.1. North America Women's Health Market Overview
- 23.2. North America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Women's Health Market
- 24.1. USA Women's Health Market Overview
- 24.2. USA Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Women's Health Market
- 25.1. Canada Women's Health Market Overview
- 25.2. Canada Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Women's Health Market
- 26.1. South America Women's Health Market Overview
- 26.2. South America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Women's Health Market
- 27.1. Brazil Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Women's Health Market
- 28.1. Middle East Women's Health Market Overview
- 28.2. Middle East Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Women's Health Market
- 29.1. Africa Women's Health Market Overview
- 29.2. Africa Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Women's Health Market Competitive Landscape And Company Profiles
- 30.1. Women's Health Market Competitive Landscape
- 30.2. Women's Health Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Agile Therapeutics Overview, Products and Services, Strategy and Financial Analysis
31. Women's Health Market Other Major And Innovative Companies
- 31.1. Apothecus Pharmaceutical Corporation
- 31.2. Blairex Laboratories Inc.
- 31.3. Novartis AG
- 31.4. AstraZeneca PLC
- 31.5. F. Hoffmann-La Roche Ltd.
- 31.6. Ferring Pharmaceuticals
- 31.7. Lupin Pharmaceuticals Inc.
- 31.8. Johnson & Johnson Services Inc.
- 31.9. Eli Lilly and Company
- 31.10. Teva Pharmaceutical Industries Ltd.
- 31.11. Hologic Inc.
- 31.12. Celmatix Inc.
- 31.13. HERA Biotech Inc.
- 31.14. Juno Bio Inc.
- 31.15. Maven Clinic Inc.
32. Global Women's Health Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Women's Health Market
34. Recent Developments In The Women's Health Market
35. Women's Health Market High Potential Countries, Segments and Strategies
- 35.1 Women's Health Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Women's Health Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Women's Health Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
